No Data
Qianhai Health (00911.HK): Wu Hongru appointed as an independent non-executive director.
Galun Hui announced on November 22 that qianhai health (00911.HK) has appointed Wu Hongru as an independent non-executive director and the chair of the audit committee, effective from November 22, 2024. Lin Jie has resigned as a non-executive director, effective from the same date.
We Think That There Are Some Issues For Qianhai Health Holdings (HKG:911) Beyond Its Promising Earnings
QIANHAI HEALTH: 2024 INTERIM REPORT
Qianhai Health [00911] is now trading at HKD 0.229, with a gain of 14.50%.
As of 13:36, qianhai health [00911] reported 0.229 Hong Kong dollars, up 0.029 Hong Kong dollars or 14.50% from the closing price of 0.2 Hong Kong dollars yesterday, with a turnover of 0.0023 million Hong Kong dollars. The highest price today is 0.229 Hong Kong dollars, and the lowest price is 0.229 Hong Kong dollars. Based on the closing price yesterday, the 10-day average price is 0.36 Hong Kong dollars, and the 50-day average price is 0.36 Hong Kong dollars. The current pe ratio is -1.03 times, and the 14-day relative strength index is 42.00.
Qianhai Health (00911) fell 42.20%, now trading at 0.185 yuan, hitting a new 52-week low.
As of 11:07, Qianhai Health (00911) fell by 42.20% compared to the previous closing price, now trading at 0.185 yuan, hitting a 52-week low; volume of 0.31 million shares, turnover of 0.0576 million Hong Kong dollars.
Qianhai Health Reveals Board and Committee Members
No Data
